Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreبدمج عقدين من توافق الخبرات القطاعية والمعيشية وتطوير الخدمة في National Eating Disorders Collaboration (NEDC) قامت
(I الشكل) نموذج للنظام المتدرج…
Drugs, Alcohol and Eating Disorders Editor’s Note: Welcome to a New Year with the NEDC!
Read moreThe stepped system of care for eating disorders delivers coordinated, evidence-based services that increase or decrease in intensity according to a person's changing psychological, physical, nutritional, and functional needs.
Read more